Barry V. L. Potter, MA DPhil DSc FRSB FRSC MAE FMedSci
Affiliations: | Max-Planck-Institute for Experimental Medicine, Göttingen, Germany | ||
| 1984-1990 | Biological Chemistry | University of Leicester, Leicester, England, United Kingdom | |
| 1990- | Medicine & Biological Chemistry | University of Bath, Bath, England, United Kingdom | |
| 1998-2010 | Sterix Ltd. | ||
| 2015- | Pharmacology | University of Oxford, Oxford, United Kingdom |
Area:
medicinal chemistry, drug discovery, pharmacologyWebsite:
https://pharm.ox.ac.uk/research/potter-group-medicinal-biological-chemistry-drug-discoveryGoogle:
"Barry Potter"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Gordon Lowe | grad student | 1977-1981 | Oxford |
| Fritz Eckstein | post-doc | 1981-1983 | Max-Planck-Institute for Experimental Medicine in Goettingen |
Children
Sign in to add trainee| Megan Shipton | grad student | Oxford | |
| Nicola Howarth | post-doc | University of Bath, England | |
| Marie Migaud | post-doc | University of Bath, England | |
| Stephen Mills | post-doc | Oxford | |
| Kana M. Sureshan | post-doc | University of Bath, England | |
| Joanna Watt | post-doc | Oxford | |
| Lawrence L.W. Woo | post-doc | University of Bath, England | |
| Gerd K Wagner | post-doc | 2002-2004 | University of Bath |
| Wolfgang Dohle | research scientist | Oxford | |
| Andrew M Riley | research scientist | Oxford | |
| Xiangdong Su | research scientist | Oxford |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Löhndorf A, Hosang L, Dohle W, et al. (2021) 2-Methoxyestradiol and its derivatives inhibit store-operated Ca entry in T cells: identification of a new and potent inhibitor. Biochimica Et Biophysica Acta. Molecular Cell Research. 118988 |
| Su X, Dohle W, Mills SJ, et al. (2020) Inositol Adenophostin: Convergent Synthesis of a Potent Agonist of d--Inositol 1,4,5-Trisphosphate Receptors. Acs Omega. 5: 28793-28811 |
| Bailey HV, Mahon MF, Vicker N, et al. (2020) Rapid and Efficient Microwave-Assisted Friedländer Quinoline Synthesis. Chemistryopen. 9: 1113-1122 |
| Chin AC, Gao Z, Riley AM, et al. (2020) The inositol pyrophosphate 5-InsP drives sodium-potassium pump degradation by relieving an autoinhibitory domain of PI3K p85α. Science Advances. 6 |
| Whitfield H, White G, Sprigg C, et al. (2020) An ATP-responsive metabolic cassette comprised of inositol tris/tetrakisphosphate kinase 1 (ITPK1) and inositol pentakisphosphate 2-kinase (IPK1) buffers diphosphosphoinositol phosphate levels. The Biochemical Journal. 477: 2621-2638 |
| Shipton M, Riley AM, Rossi AM, et al. (2020) Both D- and L-glucose polyphosphates mimic D-myo-inositol 1,4,5-trisphosphate: new synthetic agonists and partial agonists at the Ins(1,4,5)P3 receptor. Journal of Medicinal Chemistry |
| White G, Prior C, Mills SJ, et al. (2020) Regioisomeric Family of Novel Fluorescent Substrates for SHIP2. Acs Medicinal Chemistry Letters. 11: 309-315 |
| Mills SJ, Rossi AM, Konieczny V, et al. (2020) D-chiro-Inositol Ribophostin: a Highly Potent Agonist at D-myo-Inositol 1,4,5-Trisphosphate Receptors: Synthesis and Biological Activities. Journal of Medicinal Chemistry |
| Baszczyňski O, Watt JM, Rozewitz MD, et al. (2020) Synthesis of phosphonoacetate analogues of the second messenger adenosine 5'-diphosphate ribose (ADPR). Rsc Advances. 10: 1776-1785 |
| Shen YC, Arellano-Garcia C, Menjivar RE, et al. (2019) Nonsteroidal sulfamate derivatives as new therapeutic approaches for Neurofibromatosis 2 (NF2). Bmc Pharmacology & Toxicology. 20: 67 |